185 related articles for article (PubMed ID: 22568144)
1. [Anti SSPE drugs].
Hosoya M
Nihon Rinsho; 2012 Apr; 70(4):625-8. PubMed ID: 22568144
[TBL] [Abstract][Full Text] [Related]
2. [Therapy and prognosis in subacute sclerosing panencephalitis].
Hosoya M
Nihon Rinsho; 2007 Aug; 65(8):1483-6. PubMed ID: 17695288
[TBL] [Abstract][Full Text] [Related]
3. [Subacute sclerosing panencephalitis (SSPE)].
Hosoya M
Rinsho Shinkeigaku; 2011 Nov; 51(11):1047-50. PubMed ID: 22277474
[TBL] [Abstract][Full Text] [Related]
4. [Subacute sclerosing panencephalitis: combined treatment with interferon alpha and intraventricular ribavirin].
del Toro-Riera M; Macaya-Ruiz A; Raspall-Chaure M; Tallada-Serra M; Pasqual-López I; Roig-Quilis M
Rev Neurol; 2006 Mar 1-15; 42(5):277-81. PubMed ID: 16538590
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis.
Hosoya M; Mori S; Tomoda A; Mori K; Sawaishi Y; Kimura H; Shigeta S; Suzuki H
Antimicrob Agents Chemother; 2004 Dec; 48(12):4631-5. PubMed ID: 15561836
[TBL] [Abstract][Full Text] [Related]
6. The cooperative effect of interferon-alpha and ribavirin on subacute sclerosing panencephalitis (SSPE) virus infections, in vitro and in vivo.
Takahashi T; Hosoya M; Kimura K; Ohno K; Mori S; Takahashi K; Shigeta S
Antiviral Res; 1998 Jan; 37(1):29-35. PubMed ID: 9497070
[TBL] [Abstract][Full Text] [Related]
7. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.
Hosoya M; Shigeta S; Mori S; Tomoda A; Shiraishi S; Miike T; Suzuki H
Antimicrob Agents Chemother; 2001 Mar; 45(3):943-5. PubMed ID: 11181386
[TBL] [Abstract][Full Text] [Related]
8. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.
Solomon T; Hart CA; Vinjamuri S; Beeching NJ; Malucci C; Humphrey P
J Child Neurol; 2002 Sep; 17(9):703-5. PubMed ID: 12503650
[TBL] [Abstract][Full Text] [Related]
9. [Antiviral treatment of subacute sclerosing panencephalitis].
Sobczyk W; Kulczycki J
Neurol Neurochir Pol; 1981; 15(2):143-8. PubMed ID: 6167886
[TBL] [Abstract][Full Text] [Related]
10. Report of two children with subacute sclerosing panencephalitis displaying an atypical clinical course.
Tepebaşili I; Caksen H; Odabaş D; Ataş B; Akbayram S
J Emerg Med; 2004 Apr; 26(3):356-9. PubMed ID: 15028344
[No Abstract] [Full Text] [Related]
11. Subacute sclerosing panencephalitis: an update.
Gutierrez J; Issacson RS; Koppel BS
Dev Med Child Neurol; 2010 Oct; 52(10):901-7. PubMed ID: 20561004
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Effect of Favipiravir (T-705) against Measles and Subacute Sclerosing Panencephalitis Viruses.
Hashimoto K; Maeda H; Miyazaki K; Watanabe M; Norito S; Maeda R; Kume Y; Ono T; Chishiki M; Suyama K; Sato M; Hosoya M
Jpn J Infect Dis; 2021 Mar; 74(2):154-156. PubMed ID: 32863356
[TBL] [Abstract][Full Text] [Related]
13. Subacute sclerosing panencephalitis: a case report.
Praticò AD; Saporito M; Iacono O; Castellano-Chiodo D; Pavone P
Minerva Pediatr; 2011 Feb; 63(1):73-78. PubMed ID: 21311432
[TBL] [Abstract][Full Text] [Related]
14. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.
Haddad FS; Risk WS
Ann Neurol; 1980 Feb; 7(2):185-8. PubMed ID: 6154441
[TBL] [Abstract][Full Text] [Related]
15. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex.
Dyken PR; Swift A; DuRant RH
Ann Neurol; 1982 Apr; 11(4):359-64. PubMed ID: 6179455
[TBL] [Abstract][Full Text] [Related]
17. Treatment of subacute sclerosing panencephalitis: an overview.
Taylor WJ; DuRant RH; Dyken PR
Drug Intell Clin Pharm; 1984 May; 18(5):375-81. PubMed ID: 6202474
[TBL] [Abstract][Full Text] [Related]
18. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters.
Honda Y; Hosoya M; Ishii T; Shigeta S; Suzuki H
Antimicrob Agents Chemother; 1994 Apr; 38(4):653-5. PubMed ID: 8031027
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis.
Anlar B; Aydin OF; Guven A; Sonmez FM; Kose G; Herguner O
Clin Ther; 2004 Nov; 26(11):1890-4. PubMed ID: 15639700
[TBL] [Abstract][Full Text] [Related]
20. Fulminating adult-onset subacute sclerosing panencephalitis in a 49-year-old man.
Gagnon A; Bouchard RW
Arch Neurol; 2003 Aug; 60(8):1160-1. PubMed ID: 12925376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
